The COVID-19 pandemic has led to a dramatic increase in patients presenting with type 1
respiratory failure. In order to protect our limited critical care capacity, we rapidly developed …

Methods We included all patients commenced on CPAP as a ceiling-of-care for treatment of
respiratory failure due to COVID-19, on the wards of two large UK hospitals. Data were …

The aim of this case series is to describe and evaluate our experience of continuous positive
airway pressure (CPAP) to treat type 1 respiratory failure in patients with COVID-19. CPAP …

Objective We developed a national survey to assess the changes implemented by
respiratory departments across England in response to the first wave of the COVID‐19 …

Background NHS England recommends non-invasive continuous positive airway pressure
(CPAP) as a possible treatment for type 1 respiratory failure associated with COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes
(COVID-19) has proven to be the greatest challenge to modern global health care, infecting …

Discussion: Limitation of bed numbers in ICU has caused unforeseen stress upon the
system to manage sudden increase of severe acute respiratory distress syndrome during …

Introduction and Objectives The COVID-19 pandemic saw unprecedented pressure placed
upon healthcare services and demand for additional Critical Care capacity. National …

Objective To evaluate the role of continuous positive air pressure (CPAP) in the
management of respiratory failure associated with COVID-19 infection. Early clinical …

Continuous positive airway pressure (CPAP) has been suggested as a beneficial treatment
for patients with coronavirus disease 2019 (COVID-19). The objective of CPAP treatment is …